Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umberto Cillo

Showing results (381-390 of 410) with videos related to

Pageof 41
Sort By:
Annals of Surgery|September 5, 2020
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active TumorsAndreas A Schnitzbauer, Natalie Filmann, René Adam, et al.
Hepatology (Baltimore, Md.)|January 16, 2023
Model to predict major complications following liver resection for HCC in patients with metabolic syndromeGiammauro Berardi, Francesca Ratti, Carlo Sposito, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 8, 2025
Liver transplantation for hepatitis D virus/hepatitis B virus coinfection in Italy: an intention-to-treat analysis of long-term outcomesRoberta Angelico, Silvia Trapani, Tommaso Maria Manzia, et al.
JHEP Reports : Innovation in Hepatology|February 25, 2026
HCC recurrence in liver transplants treated with hypothermic oxygenated machine perfusion: An international matched cohort studyJanina Eden, Philip C Müller, Christoph Kuemmerli, et al.
Annals of Surgery|March 30, 2023
Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic SyndromeGiammauro Berardi, Tommy Ivanics, Gonzalo Sapisochin, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 16, 2025
Minimally invasive versus open liver resection for nonmetastatic hepatocellular carcinoma staged BCLC - B and - C: an Italian multicentric analysisGianluca Cassese, Mariano C Giglio, Alessandro Vitale, et al.
Annals of Surgery|June 28, 2024
Harmonizing Definitions and Perspectives in Extreme Liver Surgery: A Delphi Experts ConsensusVictor Lopez-Lopez, Peter Lodge, Karl Oldhafer, et al.
JHEP Reports : Innovation in Hepatology|July 4, 2024
Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndromeGiammauro Berardi, Alessandro Cucchetti, Carlo Sposito, et al.
Journal of Hepatology|April 7, 2025
Deceased donor liver utilisation and assessment: Consensus guidelines from the European Liver and Intestine Transplant AssociationAmelia J Hessheimer, Hermien Hartog, Francesca Marcon, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 12, 2025
Laparoscopic versus open resection for hepatocellular carcinoma according to the procedure's complexity: real-world weighted data from a national registerSimone Famularo, Flavio Milana, Francesco Ardito, et al.
Pageof 41

Showing results (381-390 of 410) with videos related to

Sort By:
Pageof 41
Annals of Surgery|September 5, 2020
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active TumorsAndreas A Schnitzbauer, Natalie Filmann, René Adam, et al.
Hepatology (Baltimore, Md.)|January 16, 2023
Model to predict major complications following liver resection for HCC in patients with metabolic syndromeGiammauro Berardi, Francesca Ratti, Carlo Sposito, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 8, 2025
Liver transplantation for hepatitis D virus/hepatitis B virus coinfection in Italy: an intention-to-treat analysis of long-term outcomesRoberta Angelico, Silvia Trapani, Tommaso Maria Manzia, et al.
JHEP Reports : Innovation in Hepatology|February 25, 2026
HCC recurrence in liver transplants treated with hypothermic oxygenated machine perfusion: An international matched cohort studyJanina Eden, Philip C Müller, Christoph Kuemmerli, et al.
Annals of Surgery|March 30, 2023
Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic SyndromeGiammauro Berardi, Tommy Ivanics, Gonzalo Sapisochin, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 16, 2025
Minimally invasive versus open liver resection for nonmetastatic hepatocellular carcinoma staged BCLC - B and - C: an Italian multicentric analysisGianluca Cassese, Mariano C Giglio, Alessandro Vitale, et al.
Annals of Surgery|June 28, 2024
Harmonizing Definitions and Perspectives in Extreme Liver Surgery: A Delphi Experts ConsensusVictor Lopez-Lopez, Peter Lodge, Karl Oldhafer, et al.
JHEP Reports : Innovation in Hepatology|July 4, 2024
Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndromeGiammauro Berardi, Alessandro Cucchetti, Carlo Sposito, et al.
Journal of Hepatology|April 7, 2025
Deceased donor liver utilisation and assessment: Consensus guidelines from the European Liver and Intestine Transplant AssociationAmelia J Hessheimer, Hermien Hartog, Francesca Marcon, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 12, 2025
Laparoscopic versus open resection for hepatocellular carcinoma according to the procedure's complexity: real-world weighted data from a national registerSimone Famularo, Flavio Milana, Francesco Ardito, et al.
Pageof 41